- Latest week
- 10 Jul 2026
- Close
- 2.100000
- Fair value
- 1.673847
- Next-week expectancy
- Negative 39.60%
SPRO Chart Pack
Spero Therapeutics Inc
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, SPRO fell 23.36%, moving from 2.74 to 2.10. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 10 of the last 12 weeks. Relative Strength is -23.29 and has softened across the 12-week window. Market Dynamics is -1.06 on the latest week. Next-week expectancy is negative at 39.60% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 2.10
- 12-Week Change
- -23.36%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 39.60%
- Signal Weeks
- 10 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- -23.29
- Market Dynamics
- -1.06
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 2.10
- 12-Week Change
- -23.36%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 39.60%
- Signal Weeks
- 10 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- -23.29
- Market Dynamics
- -1.06
Over the latest 12 completed weeks ending 2026-07-10, SPRO fell 23.36%, moving from 2.74 to 2.10. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 10 of the last 12 weeks. Relative Strength is -23.29 and has softened across the 12-week window. Market Dynamics is -1.06 on the latest week. Next-week expectancy is negative at 39.60% based on similar historical setup states.
Industry Peers
United States equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| FBRX Forte Biosciences Inc | NASDAQ | 10 Jul 2026 | 20.81 | 45.36 | 19.95 | 43.92 | 111.05% |
| CRNX Crinetics Pharmaceuticals Inc | NASDAQ | 10 Jul 2026 | 42.03 | 83.76 | 41.39 | 83.58 | 98.86% |
| TRAX First Tracks Biotherapeutics | NASDAQ | 10 Jul 2026 | 19.23 | 38.49 | 18.49 | 36.24 | 88.46% |
| TVRD Tvardi Therapeutics, Inc. | NASDAQ | 10 Jul 2026 | 1.95 | 5.69 | 1.95 | 3.28 | 68.21% |
| CBUS Cibus Global LLC | NASDAQ | 10 Jul 2026 | 1.39 | 2.20 | 1.36 | 2.02 | 45.32% |
| AKTX Akari Therapeutics PLC | NASDAQ | 10 Jul 2026 | 9.80 | 15.50 | 9.80 | 13.88 | 41.63% |
| VRAX Virax Biolabs Group Limited Ordinary Shares | NASDAQ | 10 Jul 2026 | 2.95 | 13.19 | 2.84 | 4.08 | 38.31% |
| AARD Aardvark Therapeutics, Inc. Common Stock | NASDAQ | 10 Jul 2026 | 5.59 | 7.92 | 4.66 | 7.60 | 35.96% |
| MSLE Satellos Bioscience Inc. Common Stock | NASDAQ | 10 Jul 2026 | 7.32 | 10.00 | 7.32 | 9.79 | 33.74% |
| TTRX Turn Therapeutics Inc. Common Stock | NASDAQ | 10 Jul 2026 | 7.18 | 11.69 | 7.10 | 9.44 | 31.48% |
| PEPG PepGen Ltd | NASDAQ | 10 Jul 2026 | 1.78 | 2.44 | 1.77 | 2.34 | 31.46% |
| CUE Cue Biopharma | NASDAQ | 10 Jul 2026 | 28.01 | 45.50 | 28.01 | 36.78 | 31.31% |
| LRMR Larimar Therapeutics Inc | NASDAQ | 10 Jul 2026 | 3.29 | 4.32 | 3.21 | 4.28 | 30.09% |
| JSPR Jasper Therapeutics Inc | NASDAQ | 10 Jul 2026 | 0.45 | 0.68 | 0.42 | 0.58 | 29.04% |
| MTVA MetaVia Inc. | NASDAQ | 10 Jul 2026 | 1.41 | 1.80 | 1.41 | 1.78 | 26.24% |
| VSTM Verastem Inc | NASDAQ | 10 Jul 2026 | 4.52 | 5.57 | 4.30 | 5.53 | 22.35% |